ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,917,000 | -6.0% | 116,939 | -25.3% | 0.87% | +25.9% |
| Q3 2016 | $4,166,000 | +9.5% | 156,547 | -9.3% | 0.69% | +17.4% |
| Q2 2016 | $3,805,000 | -35.5% | 172,557 | -14.1% | 0.59% | -28.8% |
| Q1 2016 | $5,901,000 | -18.4% | 200,926 | -8.3% | 0.83% | -32.4% |
| Q4 2015 | $7,235,000 | -19.2% | 219,098 | -11.6% | 1.23% | -9.4% |
| Q3 2015 | $8,958,000 | – | 247,856 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |